Lymphatic vessel activation in cancer

Annals of the New York Academy of Sciences

Volumn 979, Issue , 2002, Pages 120-130

  Cassella, Melanie ^a   Skobe, Mihaela ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer metastasis; Lymphangiogenesis; Lymphatic endothelium; VEGF receptor; VEGF C

Indexed keywords

VASCULOTROPIN C;

ANGIOGENESIS; CELL KINETICS; CONFERENCE PAPER; HUMAN; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; MACROMOLECULE; MACROPHAGE ACTIVATION; METASTASIS POTENTIAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0036959906     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04873.x     Document Type: Conference Paper

References (59)

1. ZETTER, B.R. 1993. Adhesion molecules in tumor metastasis. Sem. Cancer Res. 4: 219-229.
2. LIOTTA, L.A., P.S. STEEG & W.G. STETLER-STEVENSON. 1991. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336.
3. SWARTZ, M.A. & M. SKOBE. 2001. Lymphatic function, lymphangiogenesis, and cancer metastasis. Microsc. Res. Tech. 55: 92-99.
4. PULLINGER, B.D. & H.W. FLOREY. 1935. Some observations on the structure and functions of lymphatics: their behavior in local edema. Br. J. Exp. Pathol. 16: 49.
5. WITTE, M.H., D.L. WAY, C.L. WITTE, et al. 1997. Lymphangiogenesis: mechanisms, significance and clinical implications. Experientia 79: 65-112.
6. REICHERT, F.L. 1926. The regeneration of the lymphatics. Arch. Surg. 13: 871-881.
7. EVANS, H.M. 1908. On the occurence of newly formed lymphatic vessels in malignant growths. Johns Hopkins Med. J. 19: 232.
8. LEE, F.C. & R.C. TILGHMANN. 1933. Lymph vessels in rabbit carcinoma, with a note on the normal lymph vessel structure of the testis. Arch. Surg. 26: 602-616.
9. GILCHRIST, R.K. 1950. Surgical management of advanced cancer of the breast. Arch. Surg. 61: 913-929.
10. ZEIDMAN, I., B.E. COPELAND & S. WARREN. 1955. Experimental studies on the spread of cancer in the lymphatic system. II. Absence of a lymphatic supply in carcinomas. Cancer 8: 123-127.
11. FOLKMAN, J. 1996. Angiogenesis and tumor growth. N. Engl. J. Med. 334: 921.
12. LEU, A.J., D.A. BERK, A. LYMBOUSSAKI, et al. 2000. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60: 4324-4327.
13. SLEEMAN, J.P., J. KRISHNAN, V. KIRKIN, et al. 2001. Markers for the lymphatic endothelium: in search of the holy grail? Microsc. Res. Tech. 55: 61-69.
14. JAIN, R.K. & B.T. FENTON. 2002. Intratumoral lymphatic vessels: a case of mistaken identity or malfunction? J. Natl. Cancer Inst. 94: 417-421.
15. JOUKOV, V., K. PAJUSOLA, A. KAIPAINEN, et al. 1996. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15: 290-298.
16. LEE, J., A. GRAY, J. YUAN, et al. 1996. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc. Natl. Acad. Sci. USA 93: 1988-1992.
17. KUREBAYASHI, J., T. OTSUKI, H. KUNISUE, et al. 1999. Expression of vascular endothelial growth factor (VEGF) family members in breast cancer. Jpn. J. Cancer Res. 90: 977-981.
18. SALVEN, P., A. LYMBOUSSAKI, P. HEIKKILA, et al. 1998. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am. J. Pathol. 153: 103-108.
19. AKAGI, K., Y. IKEDA, M. MIYAZAKI, et al. 2000. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br. J. Cancer 83: 887-891.
20. ANDRE, T., L. KOTELEVETS, J.C. VAILLANT, et al. 2000. Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa. Int. J. Cancer 86: 174-181.
21. NIKI, T., S. IBA, M. TOKUNOU, et al. 2000. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin. Cancer Res. 6: 2431-2439.
22. OHTA, Y., H. NOZAWA, Y. TANAKA, et al. 2000. Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 119: 804-813.
23. BUNONE, G., P. VIGNERI, L. MARIANI, et al. 1999. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am. J. Pathol. 155: 1967-1976.
24. FELLMER, P.T., K. SATO, R. TANAKA, et al. 1999. Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas. Surgery 126: 1056-1061.
25. SHUSHANOV, S., M. BRONSTEIN, J. ADELAIDE, et al. 2000. VEGF-C and VEGFR3 expression in human thyroid pathologies. Int. J. Cancer 86: 47-52.
26. YONEMURA, Y., Y. ENDO, H. FUJITA, et al. 1999. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin. Cancer Res. 5: 1823-1829.
27. OHTA, Y., V. SHRIDHAR, R.K. BRIGHT, et al. 1999. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br. J. Cancer 81: 54-61.
28. EGGERT, A., N. IKEGAKI, J. KWIATKOWSKI, et al. 2000. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin. Cancer Res. 6: 1900-1908.
29. TSURUSAKI, T., S. KANDA, H. SAKAI, et al. 1999. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br. J. Cancer 80: 309-313.
30. SKOBE, M., T. HAWIGHORST, D.G. JACKSON, et al. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7: 192-198.
31. LEAK, L.V. 1970. Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface. Microvasc. Res. 2: 361-391.
32. MANDRIOTA, S.J., L. JUSSILA, M. JELTSCH, et al. 2001. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20: 672-682.
33. FISHER, B. & E.R. FISHER. 1968. Role of the lymphatic system in dissemination of tumor. In Lymph and the Lymphatic System. H.S. Mayerson, Ed.: 324. Charles C. Thomas. Springfield, IL.
34. WEISS, L. & G.W. SCHMID-SCHÖNBEIN. 1989. Biomechanical interactions of cancer cells with the microvasculature during metastasis. Cell Biophys. 14: 187-215.
35. JAIN, R.K. & T.P. PADERA. 2002. Prevention and treatment of lymphatic metastasis by antilymphangiogenic therapy. J. Natl. Cancer Inst. 94: 785-787.
36. HE, Y., K. KOZAKI, T. KARPANEN, et al. 2002. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J. Natl. Cancer Inst. 94: 819-825.
37. SKOBE, M., L.M. HAMBERG, T. HAWIGHORST, et al. 2001. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am. J. Pathol. 159: 893-903.
38. JOUKOV, V., T. SORSA, V. KUMAR, et al. 1997. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16: 3898-3911.
39. KAIPAINEN, A., J. KORHONEN, T. MUSTONEN, et al. 1995. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 92: 3566-3570.
40. JUSSILA, L., R. VALTOLA, T.A. PARTANEN, et al. 1998. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res. 58: 1599-1604.
41. FIELDER, W., U. GRAEVEN, S. ERGUN, et al. 1997. Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia. Leukemia 11: 1234-1237.
42. CARMELIET, P. & R.K. JAIN. 2000. Angiogenesis in cancer and other diseases. Nature 407: 249-257.
43. PADERA, T.P., A. KADAMBI, E.DI TOMASO, et al. 2002. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296: 1883-1886.
44. SCHMID-SCHÖNBEIN, G.W. 1990. Microlymphatics and lymph flow. Physiol. Rev. 70: 987-1028.
45. RYAN, T.J. 1989. Structure and function of lymphatics. J. Invest. Dermatol. 93: 18S-24S.
46. JAIN, R.K. 1990. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metast. Rev. 9: 253-266.
47. PAPOUTSI, M., G. SIEMEISTER, K. WEINDEL, et al. 2000. Active interaction of human A375 melanoma cells with the lymphatics in vivo. Histochem. Cell Biol. 114: 373-385.
48. PAPOUTSI, M., J.P. SLEEMAN & J. WILTING. 2001. Interaction of rat tumor cells with blood vessels and lymphatics of the avian chorioallantoic membrane. Microsc. Res. Tech. 55: 100-107.
49. STACKER, S.A., C. CAESAR, M.E. BALDWIN, et al. 2001. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 7: 186-191.
50. KARPANEN, T., M. EGEBLAD, M.J. KARKKAINEN, et al. 2001. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 61: 1786-1790.
51. MATTILA, M.M., J.K. RUOHOLA, T. KARPANEN, et al. 2002. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int. J. Cancer 98: 946-951.
52. WIGLE, J.T., N. HARVEY, M. DETMAR, et al. 2002. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 21(7): 1505-1513.
53. SCHOPPMANN, S.F., P. BIRNER, P. STUDER & S. BREITENEDER-GELEFF. 2001. Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer Res. 21(4A): 2351-2355.
54. BEASLEY, N.J., R. PREVO, S. BANERJI, et al. 2002. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res. 62(5): 1315-1320.
55. BIRNER, P., M. SCHINDL, A. OBERMAIR, et al. 2001. Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int. J. Cancer 95: 29-33.
56. BIRNER, P., M. SCHINDL, A. OBERMAIR, et al. 2000. Lymphatic microvessel density in epithelial ovarian cancer: its impact on prognosis. Anticancer Res. 20: 2981-2985.
57. DE WAAL, R.M., M.C. VAN ALTENA, H. ERHARD, et al. 1997. Lack of lyphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination. Am. J. Pathol. 150(6): 1951-1957.
58. CLARIJS, R., L. SCHALKWIJK, D.J. RUITER & R.M. DE WAAL, et al. 2001. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma. Invest. Ophthalmol. Visual Sci. 42(7): 1422-1428.
59. CARREIRA, C.M., S.M. NASSER, E. DI TOMASO, et al. 2001. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res. 61: 8079-8084.